
Proposed Increase To Glyphosate Limits
The proposed amendments change or set maximum residue levels in food sold in NZ for 14 substances, including glyphosate (used in Roundup herbicide).
Glyphosate limits would increase for certain cereal and pea crops, to 'support existing use' as a preharvest herbicide or dessicant. Submissions on the proposal closed on Friday, and the proposed amendments may progress, be modified, or be withdrawn.
The Science Media Centre asked experts to comment.
Associate Professor Melanie Kah, School of Environment, University of Auckland, comments:
'NZ Food Safety recently proposed to amend the Maximum Residue Limit for a dozen pesticides. The one for glyphosate raised concerns probably because glyphosate is often taken as an example for toxic pesticides by the public, even though it is a substance with a relatively low toxicity compared to other pesticides.
'The Maximum Residue Limit for glyphosate is proposed to be raised from a default value (0.1 mg/kg) to 10 mg/kg, which is similar or lower compared to Australian and international limits. The change is proposed to reflect potential residues resulting from current uses of glyphosate as pre-harvest desiccant following Good Agricultural Practices (i.e. how the product should be used following label instructions). It does not mean farmers will aim to have that level on produce. Surveys generally indicate that levels of residues are lower than that.
'Rather than focusing on the Maximum Residue Limit value and glyphosate in particular, I would question the practice of using herbicides as pre-harvest desiccant to facilitate harvest, which is a practice that is banned in other parts of the world e.g. Europe, mainly due to concerns related to residues on grains and impact on environmental health.'
No conflicts of interest.
Professor John D. Potter, Centre for Public Health Research, Massey University, comments:
'Glyphosate is a herbicide that now accounts for about 25% of the world's biocide use.
'Glyphosate was identified in 2015 as a probable human carcinogen by the International Agency for Research on Cancer, the cancer research arm of WHO. It has since been shown, in animal experiments, to also cause changes in intestinal microbes and the structure and permeability (increasing leakiness) of the wall of the intestine as well as altering lipid metabolism.
'Further, as it disrupts these microbes, it is probably altering the structure, function, and balance of those that live in the soil, with knock-on effects on soil quality, crop-raising, etc. It has now been banned and restricted in many countries.
'It is widespread in food and in human blood worldwide. As a consequence, it is difficult to establish the full range of impacts on human health because there are almost no unexposed people to compare with those who are exposed.
'What is clear is that as 'acceptable' levels rise, spraying will result in increased exposure for those who apply this herbicide for a living and for those who live downwind from sprayed crops.
'The Precautionary Principle would suggest that it is up to glyphosate's advocates to prove its safety and, in the absence of such proof, to reduce or eliminate exposure.
'At the very least, Aotearoa's government can be asked why they would choose now, in face of the evidence, to reduce restrictions.'
No conflicts of interest.
Professor of Toxicology Ian Shaw, School of Physical & Chemical Sciences, University of Canterbury, comments:
'The government is proposing an increase in the Maximum Residue Level for the herbicide glyphosate (the active ingredient in Roundup) from the default level of 0.1 mg/kg to 10.0 mg/kg.
'Pesticide Maximum Residue Levels are determined by measuring the concentration in a crop that was treated with the pesticide under Good Agricultural Practice. Maximum Residue Levels are trading standards, not consumer safety measures.
'The Acceptable Daily Intake is a consumer safety standard. Estimating glyphosate intake at the proposed new MRL (for example in wheat) shows that the proposed limit is of little or no toxicological concern. For glyphosate, the Acceptable Daily Intake is based on long term effects in rats.
'The government is also revising the genetically modified organism legislation. This might result in the approval of GM glyphosate resistant (Roundup Ready) crops in New Zealand.
'The use of glyphosate on Roundup Ready crops means higher crop residues, which would necessitate a higher Maximum Residue Level to facilitate trade. The cynic in me wonders if the two proposed legislative changes are linked.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Otago Daily Times
8 hours ago
- Otago Daily Times
Opinion: New Zealand needs more doctors, but is a new medical school the solution?
New Zealand desperately needs more doctors, especially general practitioners. However, the government's own analysis shows that its flagship solution — building a brand-new medical school in Waikato — is deeply flawed. The government said a Waikato Medical School would be a cheaper, faster route to training more doctors. However, the detailed business case — which is meant to ensure government projects deliver value for money and was released nearly a week later — shows this decision was based on misleading assumptions and omissions. Firstly, the government's pitch hinges on the Waikato school being a four-year graduate-entry programme, supposedly cheaper than the current six-year degrees at Otago and Auckland universities. What they conveniently omit is that students must first complete a minimum three-year bachelors degree before even starting. The government claimed running costs will be cheaper because of a shorter degree but had never considered trialling the four-year graduate model at Otago or Auckland, where infrastructure and proven teaching expertise already exist. Why build an entirely new institution rather than simply expanding existing, successful schools? Furthermore, the government modelled its plan on an Australian programme, assuming it would increase the number of GPs working rurally here. That's a risky assumption. The business case estimated that 38% of Waikato graduates would become general practitioners, compared to 23% if intake was increased at Auckland and Otago, and 33% through a joint rural training programme. This is speculation and contradicted by Prof Warwick Bagg, Dean of the University of Auckland's medical school, who said current programmes already had around 35% of graduates working as a GP eight years after graduation. There are also questions around what impact Waikato will have on Otago's existing rural programme and what effect it will have on placements already aligned with the university. The Waikato medical school was pitched to National as a political "gift" and the government has cherry-picked facts and overlooked other options. For example, Otago and Auckland universities could expand their intakes now, producing more doctors faster in proven, established environments that require only increased funding — not costly new infrastructure. Christopher Luxon's government is out of touch, prioritising pet projects, instead of focusing on the delivering what New Zealand needs. Rather than chasing a political headline, the government could look to support and expand the medical schools we already have. Our health system and patients deserve no less.


Techday NZ
3 days ago
- Techday NZ
OneMRI raises AUD $2.5m to expand preventive MRI scan service
Australian startup OneMRI has raised AUD $2.5 million in seed capital to expand its national service offering preventive whole-body MRI scans for early detection of a wide range of health conditions. Funding round The seed round was oversubscribed, with participation from investors including OIF Ventures, TEN13, Antler, Salus Ventures, AfterWork Ventures, Archangel Ventures, Black Sheep Capital, Prtnr, Larsen Ventures, Tribe Global Ventures, as well as several clinicians and radiologists. The funding aims to support OneMRI's growth across Australia to meet increasing consumer interest in proactive health management. OneMRI was founded in October 2024 by Dr. Vu Tran and Andrew Barnes, known for their work at Go1, alongside entrepreneur Gopi Sara. The company markets itself as Australia's first and only national provider of whole-body MRI scans, designed to enable early detection of over 500 potential health conditions including cancers, metabolic disorders, benign growths, autoimmune conditions such as MS, spinal degeneration, and brain aneurysms. Preventive health model The clinical approach at OneMRI is supported by research and development, with scan reviews by radiologists and consultations with doctors to ensure clinical rigour. The scans are intended to complement, not replace, more targeted diagnostic tests. Gopi Sara, OneMRI Co-founder and Chief Executive Officer, described the firm's emphasis on an ethical and patient-focused process. "OneMRI's process is genuinely customer-centric, with a rigorous eligibility and informed consent framework. We have a duty of care to every individual, which is why thoughtful screening is at the core of our approach. Every appointment includes both a pre- and post-scan consultation with qualified clinicians and dedicated care coordinators - ensuring patients fully understand the process, their results and what potential next steps might look like." OneMRI partners with radiology providers such as Scan Medical and Pinnacle Medical Imaging, and collaborates with healthcare professionals and wellness brands including The Banyans, Evergreen Doctors, Melbourne Functional Medicine, and Longev. By partnering with underutilised clinics, the company utilises MRI machines operating below capacity without increasing strain on existing healthcare resources. Sector growth and patient access Dr. Vu Tran, Co-Founder and Head of Medical, OneMRI, highlighted the increasing relevance of preventive health and technology in the sector. "Wellness and preventive health are only going to grow as sectors - and technology will play a critical role in that evolution. Right now, radiology is one of the most underutilised tools in preventive care. The 'health curious' increasingly want autonomy, access, and answers. Individuals should have the agency to take a proactive approach to their health, and whole-body MRI scans are one of the safest ways to do that - offering a multi-system snapshot in a single, radiation-free investigation. Our aim is to increase OneMRI's footprint and accessibility through market growth and product innovation. We've already seen everyday Australians, from schoolteachers to nurses, benefit from our scans, and believe that we have an important part to play as more people take a proactive approach to their long-term health." Early adopters of the service have already identified previously undetected life-threatening conditions. Michelle, 49, a Life Coach from Sydney, commented on her reasons for participating: "I did a preventive MRI not out of fear, but because I believe in being proactive with my health. It gave me peace of mind and reminded me how important it is to listen to our bodies and take care of ourselves before something feels wrong." David Shein, Partner at OIF Ventures, remarked on the investment: "Investing in OneMRI is not only an exceptional opportunity to back a fast-growing sector, but it's also a way for us to support improved and more accessible care for Australians over time. I've been very impressed with what the team has achieved to date, and anticipate strong future growth for the company." Current operations and expansion OneMRI currently provides its services in Brisbane, the Gold Coast, Perth, Sydney, Newcastle, and Melbourne, with further locations expected to be added as expansion continues. The company is also preparing to offer its services across the Asia Pacific region in future international growth plans.

1News
7 days ago
- 1News
Philip Polkinghorne may give evidence at inquest into wife's death
The Auckland eye surgeon found not guilty of killing his wife after a lengthy murder trial last year may give evidence at her coronial inquest next year. Pauline Hanna, who managed the rollout of the Covid-19 vaccine as an executive director at Counties Manukau Health, died in her Remuera home on April 5, 2021. Her husband, former Auckland eye surgeon Philip Polkinghorne, was found not guilty of her murder after an eight-week trial. A pre-hearing conference has taken place in the North Shore District Court this morning with a number of key figures from the trial appearing in court once again. Polkinghorne and his lawyer Ron Mansfield were present, alongside Pauline's brother Bruce Hanna, and niece Rose, and lawyer Alysha McClintock representing the police. ADVERTISEMENT There was also a large media presence, including author Steve Braunias who has written a book about the trial, Polkinghorne, and documentary maker Mark McNeill. Coroner Tania Tetitaha laid out a timeline for lawyers to produce evidence for the inquest. She gave them 28 days to come up with agreed facts and contested evidence. The coroner asked if Polkinghorne would be available to appear before the inquest in August next year. Philip Polkinghorne leaves the North Shore District Court. (Source: 1News) Mansfield said Polkinghorne could make himself available. She deemed it relevant, saying he would know best the stressors in her life leading up to Hanna's death, as her husband. ADVERTISEMENT Mansfield raised concerns around how far back evidence would be collected for the inquest, calling a submission filed by the police a "pseudo-prosecution" of Polkinghorne. "The main issue is going to be what happened on that evening, I have no doubt about that," Tetitaha said. It was revealed in July Australian sex worker Madison Ashton, Polkinghorne's former lover, had asked to give evidence at the inquest. Tetitaha brought up Asthon's potential evidence, saying it would be useful to hear from Polkinghorne on what was presented. The Crown argued during his criminal trial held in the High Court at Auckland Polkinghorne killed his wife after a possible violent struggle, while he may have been under the influence of methamphetamine. His defence maintained Hanna died by suicide after many years of struggling with depression, compounded by work-related stress. The inquest is expected to get underway in August 2026. ADVERTISEMENT